These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7984152)
1. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Ma ZQ; Santagati S; Patrone C; Pollio G; Vegeto E; Maggi A Mol Endocrinol; 1994 Jul; 8(7):910-8. PubMed ID: 7984152 [TBL] [Abstract][Full Text] [Related]
2. SK-ER3 neuroblastoma cells as a model for the study of estrogen influence on neural cells. Agrati P; Garnier M; Patrone C; Pollio G; Santagati S; Vegeto E; Maggi A Brain Res Bull; 1997; 44(4):519-23. PubMed ID: 9370219 [TBL] [Abstract][Full Text] [Related]
3. Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Ma ZQ; Spreafico E; Pollio G; Santagati S; Conti E; Cattaneo E; Maggi A Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3740-4. PubMed ID: 8475123 [TBL] [Abstract][Full Text] [Related]
4. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840 [TBL] [Abstract][Full Text] [Related]
5. Decrease of the number of opioid receptors and of the responsiveness to morphineduring neuronal differentiation induced by 17beta-estradiol in estrogen receptor-transfected neuroblastoma cells (SK-ER3). Maggi R; Ma ZQ; Pimpinelli F; Maggi A; Martini L Neuroendocrinology; 1999 Jan; 69(1):54-62. PubMed ID: 9892851 [TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Grellier P; De Galle B; Babajko S Cancer Res; 1998 Apr; 58(8):1670-6. PubMed ID: 9563481 [TBL] [Abstract][Full Text] [Related]
7. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Patrone C; Ma ZQ; Pollio G; Agrati P; Parker MG; Maggi A Mol Endocrinol; 1996 May; 10(5):499-507. PubMed ID: 8732681 [TBL] [Abstract][Full Text] [Related]
8. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Sengupta K; Banerjee S; Saxena N; Banerjee SK Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328 [TBL] [Abstract][Full Text] [Related]
10. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214 [TBL] [Abstract][Full Text] [Related]
11. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. Bradley LM; Gierthy JF; Pentecost BT J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089 [TBL] [Abstract][Full Text] [Related]
12. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I. Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572 [TBL] [Abstract][Full Text] [Related]
13. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y; Chen S Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940 [TBL] [Abstract][Full Text] [Related]
15. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
16. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152 [TBL] [Abstract][Full Text] [Related]
17. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302 [TBL] [Abstract][Full Text] [Related]
19. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Martin MB; Franke TF; Stoica GE; Chambon P; Katzenellenbogen BS; Stoica BA; McLemore MS; Olivo SE; Stoica A Endocrinology; 2000 Dec; 141(12):4503-11. PubMed ID: 11108261 [TBL] [Abstract][Full Text] [Related]